Lilly Endowment Elects Lechleiter to its Board of Directors


John Lechleiter has been elected to serve on the Board of Directors of Lilly Endowment Inc., effective December 1, 2018. Lechleiter is the former chairman, president and chief executive officer of Eli Lilly and Company. 

For more information, visit

2018 Annual Report cover

The IBRI 2018 Annual Report is now available. The report theme is “Discovery With Purpose,” which is also the IBRI’s motto as it reflects the Institute’s commitment to translating scientific discovery into improved outcomes for patients.